| Product Code: ETC13102987 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Burkina Faso`s import of plasma protein therapeutics in 2024 showed a high concentration of shipments from top exporting countries including the USA, Italy, Denmark, France, and Germany. The Herfindahl-Hirschman Index (HHI) remained at a very high level, indicating a concentrated market. Despite a significant negative compound annual growth rate (CAGR) of -30.51% during 2020-2024, the growth rate in 2024 experienced a sharp decline of -75.56%. This data suggests a challenging market environment for plasma protein therapeutic imports in Burkina Faso, with potential implications for the healthcare sector and accessibility to such treatments.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Burkina Faso Plasma Protein Therapeutic Market Overview |
3.1 Burkina Faso Country Macro Economic Indicators |
3.2 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Burkina Faso Plasma Protein Therapeutic Market - Industry Life Cycle |
3.4 Burkina Faso Plasma Protein Therapeutic Market - Porter's Five Forces |
3.5 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Burkina Faso Plasma Protein Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Burkina Faso Plasma Protein Therapeutic Market Trends |
6 Burkina Faso Plasma Protein Therapeutic Market, By Types |
6.1 Burkina Faso Plasma Protein Therapeutic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Immunoglobulins, 2021 - 2031F |
6.1.4 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Albumin, 2021 - 2031F |
6.1.5 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Clotting Factors, 2021 - 2031F |
6.1.6 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Alpha-1 Antitrypsin, 2021 - 2031F |
6.1.7 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Burkina Faso Plasma Protein Therapeutic Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Human Plasma, 2021 - 2031F |
6.2.3 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Blood Plasma, 2021 - 2031F |
6.2.4 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Factor VIII, IX, 2021 - 2031F |
6.2.5 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Genetic Plasma, 2021 - 2031F |
6.2.6 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Burkina Faso Plasma Protein Therapeutic Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Hemophilia Centers, 2021 - 2031F |
6.3.5 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.3.6 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Burkina Faso Plasma Protein Therapeutic Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Immune Deficiency Treatment, 2021 - 2031F |
6.4.3 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Liver & Kidney Disorders, 2021 - 2031F |
6.4.4 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Blood Disorder Management, 2021 - 2031F |
6.4.5 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4.6 Burkina Faso Plasma Protein Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
7 Burkina Faso Plasma Protein Therapeutic Market Import-Export Trade Statistics |
7.1 Burkina Faso Plasma Protein Therapeutic Market Export to Major Countries |
7.2 Burkina Faso Plasma Protein Therapeutic Market Imports from Major Countries |
8 Burkina Faso Plasma Protein Therapeutic Market Key Performance Indicators |
9 Burkina Faso Plasma Protein Therapeutic Market - Opportunity Assessment |
9.1 Burkina Faso Plasma Protein Therapeutic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Burkina Faso Plasma Protein Therapeutic Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Burkina Faso Plasma Protein Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Burkina Faso Plasma Protein Therapeutic Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Burkina Faso Plasma Protein Therapeutic Market - Competitive Landscape |
10.1 Burkina Faso Plasma Protein Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Burkina Faso Plasma Protein Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |